Swipe to compare →
CALL (949) 631-4780
CALL (949) 631-4780
If you are in your late 40s, 50s, or 60s and increasingly frustrated by reading glasses, progressive lenses, glare at night, or a prescription that no longer feels stable, the issue cannot be corrected with LASIK or SMILE, because those procedures reshape the cornea to correct distance or near vision, but not both. In many patients at this stage the real problem is the aging natural lens. Had LASIK years ago and feel like it wore off? Read why LASIK does not wear off, and what actually changed.
Refractive lens exchange (RLE) replaces that aging lens with a customized intraocular lens (IOL), so distance, intermediate, and near vision can be addressed in a single procedure. As a bonus, future cataract surgery is no longer a separate event waiting down the road.
Feinerman Vision offers refractive lens exchange, also called custom lens replacement, at our Newport Beach practice, serving Orange County and greater Los Angeles. Dr. Gregg Feinerman personally performs every consultation and every surgery, and lens selection is never one-size-fits-all: it is personalized to your anatomy, lifestyle, and goals using iTrace, Pentacam, IOL Master, and OCT imaging, drawing on every IOL technology available in the USA, including the Light Adjustable Lens (LAL), Clareon® PanOptix® Pro, Clareon® Vivity®, FINEVISION HP, and enVista.
Dr. Gregg Feinerman has been performing intraocular lens surgery in Newport Beach since 2001. He was the first surgeon in Orange County to implant the Crystalens accommodating IOL in 2003, following its FDA approval that November as the first accommodating intraocular lens available in the United States. During its commercial era, he performed more Crystalens implants than any other California surgeon. That early adoption pattern has continued through every generation of premium IOL technology since, including service as Principal Investigator on more than ten FDA-registered clinical trials for intraocular lens and ophthalmic surgical technology.
Swipe to compare →
| Feature | RLE | EVO ICL™ | Cataract Surgery |
|---|---|---|---|
| Typical Age | 50 and above | 21 to 60 | 60 and above (or when cataract develops) |
| Indication | Elective | Elective | Medical (cataract present) |
| Insurance Coverage | Self-pay | Self-pay | Standard monofocal covered; premium IOL upgrade self-pay |
| Natural Lens | Removed | Preserved (ICL placed in front of it) ✓ | Removed |
| Reversibility | Permanent | Reversible (lens can be removed) ✓ | Permanent |
| Native Accommodation | Not preserved | Preserved ✓ | Not preserved |
| Corrects Presbyopia | Yes (with premium IOL) ✓ | No | Yes (with premium IOL) |
| Best for Long Eyes (axial length > 26 mm) | Use with caution | Often the safer first choice ✓ | When cataract develops |
| Prevents Future Cataract | Yes (in treated eye) ✓ | No | N/A (cataract already present) |
| Procedure Time | 15 to 20 minutes per eye | 15 to 20 minutes per eye | 15 to 20 minutes per eye |
| Visual Recovery | 24 to 48 hours | 24 hours | 24 to 48 hours |
| Lens Options Available | Full premium IOL menu ✓ | Single Collamer lens design | Full premium IOL menu (upgrade fee) ✓ |
No single procedure is right for every eye. Procedure selection is individualized at consultation.
Refractive lens exchange uses the same surgical platform as modern cataract surgery, but it is performed before a cataract is the main reason for surgery. Instead of reshaping the cornea the way LASIK does, the eye’s natural lens is removed through a small, self-sealing incision, typically 2.2 to 2.4 millimeters, and replaced with an intraocular lens chosen for each patient’s prescription, visual goals, and tolerance for tradeoffs.
The procedure itself is short. Each eye takes roughly 15 to 20 minutes in Dr. Feinerman’s surgery center. At Feinerman Vision, both eyes are performed on the same day, meaning one surgical visit and one recovery period. The surgeon, facility and anesthesia fees are billed per eye, so patients having only one eye treated are charged accordingly.Anesthesia is given as twilight sedation combined with numbing eye drops. Most patients see well enough to read a wall clock in the surgical suite within minutes of the procedure, and most are cleared to resume normal activities the following day. For selected patients, Dr. Feinerman uses the Ziemer Z8 femtosecond laser to assist specific steps of the procedure. More on when laser assistance is used appears below.
What makes RLE distinct from cataract surgery is not the surgery, it is the decision. In cataract surgery, the lens has become cloudy enough that it interferes with daily function and insurance recognizes a medical need. In RLE, the lens is becoming dysfunctional but is not yet cloudy enough to qualify as a cataract, and the patient is electing lens-based vision correction because it is the right long-term answer for their eyes.
The core thesis of this page
If you are over 45 and frustrated with your vision, the question is not only whether you still qualify for LASIK. The more important question is whether your lens is becoming the real problem. If it is, no amount of corneal laser surgery will fix it, but refractive lens exchange will.
There is no single answer. The right procedure depends on age, prescription, the shape and health of the cornea, the state of the natural lens, and what a patient actually wants to do with their vision. Dr. Feinerman’s consultation is structured around that assessment rather than a single product recommendation. One group deserves special mention: farsighted patients over 50 are often ideal RLE candidates, for reasons I explain in Farsighted After 50? Why RLE Often Fits Better Than LASIK.
Patients who benefit most from RLE typically describe a mix of the following:
These are the hallmarks of dysfunctional lens syndrome, the staged aging of the natural lens long before a cataract becomes visible on a standard exam. When the lens is driving the problem, lens-based surgery is the answer that actually addresses the underlying tissue.
One important note on candidacy. In my practice, RLE works best for patients who wear glasses for both distance and near. When distance vision is still sharp and only reading is the problem, RLE can absolutely deliver a full range of vision, but we are solving one issue rather than two. For patients who rely on glasses all day, every day, the improvement after RLE is dramatic. For patients who only need readers, the improvement is meaningful but smaller, and I often counsel those patients to weigh whether an elective intraocular surgery is the right tradeoff for their situation. Most ethical surgeons share this view.
Patients under 43 with a stable prescription, a healthy cornea, and a still-clear natural lens are usually better served by corneal laser surgery. Dr. Feinerman prefers LASIK for patients in their 20s and 30s, and will consider it up to about age 45 when a patient understands that reading glasses will still be needed as presbyopia develops. WaveLight® Plus LASIK is the most advanced excimer platform available in the United States, and Dr. Feinerman was the first surgeon in Orange County and greater Los Angeles to perform it following its FDA approval. For the right cornea and the right age, LASIK is faster, less invasive, and still the first conversation.
For patients ages 21 to 60 with moderate to high myopia (spherical equivalent of -3.00 or greater), especially those with long eyes, meaning an axial length (the front-to-back measurement of the eye) above 26 millimeters, EVO ICL is often the better first comparison. ICL places a collamer lens behind the iris and in front of the natural lens without removing it, preserving native accommodation and reducing the retinal-detachment conversation that accompanies lens removal in long eyes. In practice, the ICL-versus-RLE discussion is one of the most important conversations we have with patients in their 40s and 50s. For the full decision framework, see our guide to EVO ICL vs. refractive lens exchange.
When the natural lens has already opacified enough to interfere with daily tasks such as driving at night, reading a menu, or working at a computer, the procedure is still lens replacement, but the medical label becomes cataract surgery. Medical insurance covers cataract surgery when a standard monofocal IOL is implanted, but a standard monofocal corrects only one focal point. Patients with astigmatism will still need glasses for distance, intermediate, and near vision after a covered monofocal. Patients without astigmatism can see clearly at one distance without glasses, but not all three. This is why many cataract patients elect to upgrade to a premium IOL at the time of surgery. Premium IOLs can correct astigmatism as well as distance, intermediate, and near vision in a single procedure, with an upgrade fee paid by the patient on top of the insurance-covered portion. See our cataract surgery overview for more on how we plan those cases and which lens technologies we use.
Swipe to compare →
| Procedure | Best fit | What changes | Preserves natural accommodation | Main caution |
|---|---|---|---|---|
| RLE | Ages 50 and above. Presbyopia, hyperopia, myopia, astigmatism, dysfunctional lens symptoms, selected post-LASIK/PRK eyes | Removes the natural lens; replaces it with a customized IOL | No | Higher caution in high myopia due to retinal-detachment risk |
| LASIK | Ages 20 to 40. healthy cornea, stable prescription | Reshapes the cornea with excimer laser. Corneal change is permanent. | Yes | Does not stop lens aging, presbyopia progression, or future cataract formation |
| EVO ICL | Ages 21 to 60 with moderate to very high myopia or myopic astigmatism and adequate anterior-chamber depth | Places a collamer lens behind the iris, in front of the natural lens. Nothing is removed, and the procedure is reversible if ever needed. | Yes | Not a presbyopia solution; depends on anatomy and FDA-approved age range |
| Cataract surgery | Usually age 60 and up, but can occur at any age when a visually significant cataract develops | Removes cloudy natural lens; replaces it with an IOL (same platform as RLE) | No | Same surgical platform as RLE. Insurance covers surgery with a standard monofocal IOL, which still requires glasses. Premium IOLs for distance, intermediate, near, and astigmatism are available as a patient-paid upgrade. |
Lens selection is the part of RLE that patients research the most and surgeons worry about the most, because the right lens is not the one with the best marketing, but the one that matches a specific eye, a specific cornea, and a specific life.
The lenses below are the ones most commonly implanted at Feinerman Vision: the Light Adjustable Lens (LAL / LAL+), three FDA-approved trifocals (Clareon® PanOptix® Pro, FINEVISION HP, and enVista Envy™), the Clareon® Vivity® and TECNIS PureSee™ extended depth of focus lenses, enVista monofocal and toric lenses along with the enhanced monofocal enVista Aspire and Clareon® TruPlus, and the Apthera™ small-aperture IOL. This is not a complete list of every IOL Dr. Feinerman implants. Additional lenses are available and may be the right choice for specific clinical situations. No single lens is right for every eye. The right lens for you depends on your prescription, your cornea, your retinal health, your night-driving habits, and how much you care about reading without glasses.
| Lens option | Main advantages | Key tradeoffs | Typical candidate |
|---|---|---|---|
| Light Adjustable Lens (LAL / LAL+) | Only IOL that can be customized after surgery with UV light treatments. In the FDA pivotal trial, patients were roughly twice as likely to achieve 20/20 or better without glasses at six months vs. a monofocal control. Particularly strong in post-LASIK, post-PRK, and post-RK eyes, where lens power calculations are less predictable. | Requires 3–4 in-office UV treatments over 4–6 weeks, plus UV-protective glasses during waking hours until lock-in. More postoperative visits than a standard IOL. Excellent distance/intermediate. Some patients still want reading glasses for fine print. | Patients who want refractive precision; anyone with prior LASIK/PRK/RK; patients with astigmatism; perfectionists who value accuracy over one-step convenience. |
| Trifocal IOLs (Clareon® PanOptix® Pro, FINEVISION HP, enVista Envy™) | Strongest range of near, intermediate, and distance vision in a single lens. Three FDA-approved platforms are available in the U.S., each with distinct optical design advantages. For well-selected patients, trifocal IOLs deliver the highest rates of complete glasses independence of any lens category. | Higher halo, glare, and starburst profile of the premium lens categories. Contrast sensitivity is lower than a monofocal, especially in dim light. Not ideal for patients with retinal disease or demanding night-driving professions. | Patients who prioritize reading and near-vision freedom and will accept some night-vision tradeoffs. |
| EDOF / Extended Depth of Focus (Clareon® Vivity® & TECNIS PureSee™) | Improved intermediate and functional near vision with comparable distance to a monofocal. Visual disturbance profile closer to a monofocal than to a trifocal, with a lower halo and glare burden in comparative studies. | Less complete near-vision freedom than a trifocal. Many patients still want glasses for small print. Still a small reduction in contrast sensitivity in dim light compared with a monofocal. | Patients who want distance, computer, and functional near vision, and prefer the better night vision typical of an EDOF IOL. |
| Monofocal / Toric monofocal | Highest optical quality, best contrast sensitivity, and the lowest risk of glare and halos. Toric version corrects astigmatism. The most predictable night-driving lens. | Most patients still need reading glasses unless a mini-monovision strategy is planned. Least “freedom from glasses” positioning. | Night drivers, quality-of-vision purists, patients with retinal disease, significant glaucoma, or demanding ocular-surface issues, and patients who prefer simplicity. |
| Apthera™ small-aperture IOL | Uses a pinhole-like aperture to extend depth of focus. Useful in eyes with irregular optics, including some post-refractive and mildly aberrated corneas. | FDA-approved only for unilateral implantation in the non-dominant eye after successful fellow-eye monofocal implantation. Reduced monocular contrast. Retinal examination and follow-up planning are more complex. | Highly selected post-refractive or irregular-optics patients after detailed counseling and coordinated fellow-eye planning. |
Outcomes at Feinerman Vision are published, with sample sizes disclosed: see our results page, including our 2025 Light Adjustable Lens series of 137 eyes.
Each of the three FDA-approved trifocals brings something different to the conversation. Clareon® PanOptix® Pro (Alcon) uses ENLIGHTEN® NXT optical technology with roughly 94% light utilization and improved intermediate-to-distance contrast over the original PanOptix® platform. FINEVISION HP (BVI) is a third-generation trifocal platform with more than 15 years of global clinical experience outside the United States. It received FDA approval in October 2025. enVista Envy™ (Bausch + Lomb) is built on the glistening-free enVista hydrophobic acrylic platform and uses ActivSync™ Optic technology to reduce dysphotopsia. Dr. Feinerman selects among them based on your cornea, your astigmatism, your visual priorities, and the most current clinical data at the time of your surgery.
Clareon® Vivity® (Alcon) uses non-diffractive X-WAVE™ wavefront-shaping technology rather than splitting light the way a diffractive trifocal does, which is why its visual disturbance profile is closer to a monofocal than to a trifocal. In comparative studies, roughly 85% of Vivity® patients report little to no glare or halos, compared with about 69% of patients implanted with a trifocal IOL (Clinical Ophthalmology, 2022; DOI 10.2147/OPTH.S347382). Vivity® is often the right answer for patients who value distance clarity and quality of vision over complete freedom from reading glasses, including patients with demanding night-driving habits.
One surgical approach worth naming. For many patients, Dr. Feinerman will place a Clareon® Vivity® EDOF lens in the dominant eye and a trifocal multifocal IOL in the non-dominant eye. Both eyes see distance clearly. Both eyes see intermediate (dashboard, computer) clearly. Both eyes can read, but the trifocal provides the finest near detail. Night vision is strong because the dominant EDOF eye takes over in dim light, which is why patients with this combination rarely notice halos or glare unless they cover the dominant eye. Not every patient is a candidate for a “mix-and-match strategy”, but when the anatomy and lifestyle align, it captures most of the benefit of a trifocal with most of the night-vision quality of an EDOF.
Two lens choices deserve extra attention for patients considering RLE. First, the Light Adjustable Lens is the only IOL whose prescription can be fine-tuned after surgery, which makes it uniquely valuable for patients with prior LASIK, PRK, or RK where standard power calculations are less predictable. Second, the Apthera™ small-aperture IOL is a niche but genuinely useful tool for select post-refractive or irregular-optics eyes.
A guardrail on lens language
Most FDA labeling for premium IOLs is written for cataract surgery and aphakia, not for elective refractive lens exchange. We describe these lenses as used in lens-replacement surgery and counsel every patient in those terms. No lens carries a device-specific FDA indication for “RLE.”
Curious how the adjustable path performs in practice? Read our 2025 Light Adjustable Lens results, and if you are weighing the choice itself, start with Fixed vs. Adjustable, the first question Dr. Feinerman asks at every consultation.
The benefits worth naming plainly are the ones patients come in asking about. A well-selected RLE can reduce dependence on glasses across distance, intermediate, and near, correct astigmatism in the same surgery, deliver a broader range of correction than corneal laser surgery can reach in some eyes, and remove the possibility of a future cataract in the treated eye. For a patient in their mid-50s planning for the next 30 years of vision, that last point alone is often decisive.
The language has to stay disciplined, though. We talk about reducing dependence on glasses and tailoring vision to your lifestyle, not guaranteeing that you will never need glasses again. I have patients who had RLE 20 years ago and are still glasses-independent today, and that outcome is real. But it is not ethical to promise every patient that result, because no lens and no surgery can guarantee it. That framing is both more accurate and more protective of the patient relationship long term.
RLE is intraocular surgery. Every intraocular surgery carries risks that must be discussed honestly before a patient signs consent. The table below summarizes the risks that matter most for RLE and the language we actually use in consultation.
| Risk area | What the evidence supports, and what we say out loud during the consultation |
|---|---|
| Halos, glare, and night-driving expectations | Presbyopia-correcting lenses create some level of light-splitting artifacts. Trifocal platforms produce more halo and starburst than EDOF platforms; EDOF platforms produce a little more than monofocals. The counseling question is not whether halos are possible. It is how much near-vision freedom a patient wants, and whether they would gladly trade a small amount of night-vision purity to get it. I explain why about one in ten premium lens patients is unhappy at first, and how I prevent it. |
| Loss of accommodation | RLE removes the natural crystalline lens permanently. Even the best range-of-vision IOLs do not restore the focusing power of a 30-year-old’s natural lens. That is part of why EVO ICL is often the better answer for younger patients who still have meaningful accommodation, and why we generally recommend RLE only for patients ages 50 and above. |
| Refractive miss and expectation mismatch | The outcome is not only about surgery going well. It is about matching the implant to how a patient actually reads, drives, and works. American Society of Cataract and Refractive Surgery (ASCRS) educational material consistently emphasizes lifestyle assessment and expectation management as the single largest driver of satisfaction with premium IOLs. The Light Adjustable Lens has a unique advantage here because it allows the prescription to be adjusted after surgery if needed. |
| Ocular surface and diagnostic quality | Dry eye and meibomian gland dysfunction corrupt keratometry and biometry measurements, which in turn corrupts lens power calculations. Following the ASCRS Preoperative Ocular Surface Disease algorithm, the surface is treated and validated before any measurement is trusted for surgical planning. |
| Retinal detachment in high myopes (–6.00 D and above, or axial length >26 mm) | A 2025 British Journal of Ophthalmology systematic review found the rate after RLE was roughly 1 in 500, compared with roughly 1 in 1,000 after cataract surgery. Both remain uncommon. Part of the difference likely reflects that RLE patients are younger and more myopic to begin with. At Feinerman Vision, younger high myopes with axial lengths above 26 mm are counseled toward EVO ICL first, because ICL preserves the cornea and natural lens and does not carry the same retinal-risk profile. |
This is the part of the conversation that differentiates an elective lens-exchange practice that is honest about tradeoffs from one that is not. At Feinerman Vision, these risks are discussed by Dr. Feinerman personally, not delegated to a coordinator, and they are part of the consent process before a lens is ever ordered.
Most patients notice meaningful visual improvement within the first 24 to 48 hours and return to normal activities the day after surgery. Eye drops are tapered over three to four weeks. Swimming is avoided for about two weeks, and smoky or dusty environments are avoided for a few days. Final visual stabilization takes three to four weeks in most cases.
Recovery varies by lens. Trifocal patients may need additional time to neuroadapt to their new optics. EDOF and monofocal patients typically adapt within days. The brain needs a few weeks to learn how to use the lens. Light Adjustable Lens patients commit to a longer postoperative partnership because the value of the LAL comes from its adjustments: typically one to three light treatments followed by two lock-in treatments over 4 to 6 weeks, with RxSight UV-protective glasses worn during waking hours until the final lock-in.
This is one of the reasons the consultation matters so much. The right lens for your eye depends in part on how much postoperative commitment you can realistically make.
Before a lens is chosen, the measurements have to be trustworthy. Feinerman Vision evaluates every elective lens-exchange candidate with iTrace from Tracey Technologies and high-resolution tomography, both of which can quantify how much of the blur is coming from the cornea and how much is coming from the lens. Every candidate also undergoes OCT imaging of the optic nerve and retina using Zeiss OCT technology, because a premium IOL is only as good as the retina and optic nerve it is paired with. Ocular-surface optimization follows the American Society of Cataract and Refractive Surgery (ASCRS) Preoperative Ocular Surface Disease algorithm. Dry eye is treated and keratometry is re-verified before surgical planning begins. That workflow is the difference between a good refractive outcome and a preventable refractive surprise.
The single largest driver of postoperative refractive surprise is a measurement error that goes undetected before surgery. Keratometry and biometry numbers that look reasonable in isolation can still be wrong, and a wrong number drives a wrong lens. At Feinerman Vision, keratometry and optical biometry are measured on three separate devices for every lens-exchange candidate: the Zeiss IOLMaster, the Oculus Pentacam, and the Tracey iTrace. No single instrument determines the lens power for your eye. When the three measurements agree, we proceed with confidence. When they disagree, we investigate, treat the ocular surface if needed, and remeasure. This cross-check is slower than a single-instrument workflow, and it is the reason refractive outcomes at Feinerman Vision are consistent rather than occasional.
For the patients who benefit most, Dr. Feinerman uses the Ziemer Z8 femtosecond laser to assist specific steps of refractive lens exchange. The Z8 is most useful for precise corneal arcuate incisions in patients with astigmatism, for the capsulotomy step in younger patients whose anterior capsule is more elastic, and for patients with dense or mature lenses where a manual capsulorhexis would be more technically demanding. For RLE patients, laser assistance is included in Dr. Feinerman’s surgeon’s fee when it is the right tool for the case. It is not added as a routine upcharge on every procedure. Laser assistance is also available for medically-indicated cataract surgery, where it is offered as a separate patient-paid option.
Dr. Feinerman is board-certified by the American Board of Ophthalmology, holds a Fellow designation from the American College of Surgeons (FACS), and completed his refractive surgery fellowship at the internationally acclaimed Gimbel Eye Center in Calgary under Howard V. Gimbel, MD. Through 2019, he served as adjunct clinical professor of ophthalmology at the University of Southern California. He has performed more Crystalens surgeries than any other surgeon in California, was recognized by Bausch & Lomb with the Crystalens Millennium Society Award as one of the top five Crystalens surgeons in the United States, and has been the highest-volume site in multiple FDA multicenter trials of intraocular lens technology.
Every consultation is with Dr. Feinerman personally. Every surgical plan is his. Every postoperative visit is with him, not a rotating cast of technicians. That continuity is hard to find in larger corporate practices, and it matters most when a lens decision has to be revisited or refined.
Why your vision changes after 45 even with healthy eyes, the three stages of dysfunctional lens syndrome, and how the iTrace Dysfunctional Lens Index objectively measures lens aging before a cataract is visible.
Eye drops, LASIK, EVO ICL, or refractive lens exchange: a Newport Beach surgeon explains which vision correction option fits which patient after 50, and where the tradeoffs live.
Transparent per-eye pricing, what the all-in fee includes, and how RLE compares to a lifetime of glasses in Newport Beach.
Feinerman Vision is located at 320 Superior Ave in Newport Beach, minutes from Costa Mesa, Huntington Beach, and Irvine, and patients travel from across Orange County for refractive lens exchange. Every RLE evaluation and every procedure is performed personally by Dr. Feinerman, and your follow-up visits happen in the same Newport Beach office with the same surgeon. If you are comparing options closer to home, the evaluation is the right place to start: it will tell you whether RLE, LASIK, or EVO ICL™ fits your eyes, whichever city you are coming from.
Refractive lens exchange replaces your natural lens with a customized intraocular lens, before the lens has become cloudy enough to qualify as a cataract. It uses the same surgical platform as cataract surgery but is chosen electively to address presbyopia, significant refractive error, or dysfunctional lens syndrome.
Technically, the surgery is identical. Same incision, same phacoemulsification, same IOL technology. The difference is the indication. Cataract surgery is performed when a cloudy lens interferes with daily function and is generally covered by medical insurance. RLE is elective lens replacement performed earlier in the lens-aging spectrum and is self-pay.
Dr. Feinerman generally does not recommend LASIK for patients over 45; past that point it starts to become the wrong answer. Not because of your cornea, but because of your lens. A LASIK procedure does not stop presbyopia or prevent a future cataract. For patients in their mid-40s and beyond, the right question is often which lens-based option, EVO ICL or RLE or eventually cataract surgery, gives you the longest-lasting result.
For patients with moderate to high myopia, especially those with axial lengths above 26 millimeters, EVO ICL is often the safer comparison. ICL preserves your cornea and natural lens. It also does not raise the retinal-detachment conversation the way that lens replacement does in a highly myopic (long axial length) eye. Once presbyopia becomes the dominant issue, RLE usually re-enters the conversation.
It depends on the lens and your expectations. Trifocal platforms like Clareon® PanOptix® Pro, FINEVISION HP, and enVista Envy™ deliver the highest rates of complete spectacle independence but come with more halos and glare. EDOF lenses like Clareon® Vivity® deliver excellent distance and intermediate with lower halo burden, but many patients still want readers for very fine print. Monofocal and LAL strategies typically leave you needing weak readers unless mini-monovision is planned. Dr. Feinerman will tell you, honestly, what to expect before you pick a lens.
There is no single answer. Trifocal IOLs give the strongest reading vision, with a tradeoff of some halos around lights at night. EDOF IOLs give excellent distance and intermediate vision, with less near than a trifocal. The Light Adjustable Lens gives the most accurate refractive target and works especially well after prior LASIK, but it is not a multifocal. The right answer is the lens that matches how you actually read, drive, and work. That is what the consultation is designed to determine.
Yes, and in many ways those patients are ideal candidates for the Light Adjustable Lens specifically. Prior corneal refractive surgery makes traditional IOL power calculations less predictable. The LAL lets us adjust the prescription after surgery to compensate. Dr. Feinerman has performed refractive surgery continuously since 1999 and has managed post-LASIK and post-PRK cataract patients throughout that time. For a full explanation of how prior LASIK changes lens selection and which lenses still work, see our guide to cataract surgery after LASIK.
The most discussed is retinal detachment. A 2025 British Journal of Ophthalmology systematic review of more than 8.5 million eyes found the rate after RLE was roughly 1 in 500, compared with roughly 1 in 1,000 after cataract surgery. Both remain uncommon. The difference is meaningful, but part of it likely reflects the patient mix, because RLE patients tend to be younger and more myopic than the general cataract population, and both factors independently raise the baseline risk of retinal detachment. The study authors specifically flagged incomplete reporting of axial length as a limitation of the analysis. In practice, this is why we counsel younger high myopes toward EVO ICL first and only consider RLE when the benefit clearly outweighs the risk. For RLE patients with axial lengths above 26 millimeters, Dr. Feinerman performs a dilated retinal exam at the one-week postoperative visit specifically to check for any retinal holes, breaks, or tears. If one is identified, a brief in-office laser treatment (laser retinopexy or argon laser barrier treatment, whichever is clinically appropriate) is performed immediately to seal the lesion and reduce the risk of progression to retinal detachment.
Most patients return to normal activities the day after surgery. Vision continues to sharpen over the first several weeks. Drops are used for three to four weeks. Swimming is avoided for two weeks. Trifocal patients may continue to neuroadapt over a few weeks. EDOF and monofocal patients typically adapt within days. LAL patients commit to a 4–6 week schedule of light treatments before lock-in.
Yes, in the treated eye. Once the natural lens has been removed and replaced with an IOL, a cataract cannot form in that eye because there is no longer a natural lens to become cloudy. That is one of the most meaningful long-term benefits of RLE for patients in their 50s and 60s.
For many patients, yes, particularly those with prior LASIK, PRK, or RK, or those with astigmatism who want the highest refractive accuracy available in the United States. The LAL is the only IOL in the U.S. whose prescription can be adjusted after surgery. The tradeoff is a longer postoperative schedule with UV-protective glasses until lock-in.
Trifocal IOLs (Clareon® PanOptix® Pro, FINEVISION HP, and enVista Envy™) are designed for the broadest range of vision and the highest rates of glasses independence, including for reading. Clareon® Vivity® is a non-diffractive extended depth of focus (EDOF) lens that stretches light rather than splitting it, which gives it a visual disturbance profile much closer to a monofocal. Trifocals tend to win on reading; Vivity® tends to win on night driving and quality of vision. For many patients, Dr. Feinerman combines the two approaches by placing Vivity® in the dominant eye and a trifocal in the non-dominant eye, which captures most of the reading benefit with most of the night-vision quality. See “Can you use different lenses in each eye?” below for more on that strategy. Dr. Feinerman selects among all of these options based on your visual priorities, your cornea, your retinal anatomy, and how much you care about fine-print reading without glasses.
Yes, and for many patients this is the best approach. Dr. Feinerman will often place a Clareon® Vivity® EDOF lens in the dominant eye and a trifocal multifocal IOL in the non-dominant eye. Both eyes see distance and intermediate clearly. Both eyes can read, but the trifocal eye handles the finest print. The dominant EDOF eye takes over at night, so patients with this combination rarely notice halos or glare unless they cover the dominant eye. This strategy is not right for every eye or every lifestyle, which is why lens selection is always individualized during the consultation.
Because RLE is elective, it is not covered by medical insurance. Pricing depends on the lens chosen, since the Light Adjustable Lens, trifocals, and Clareon® Vivity® each carry different fees.
Other factors that affect total cost include whether astigmatism is being corrected at the same time. For RLE patients, femtosecond laser assistance is included in Dr. Feinerman’s surgeon’s fee when clinically indicated, though a separate $500 surgery center fee applies for the laser disposable equipment.
At Feinerman Vision, every RLE procedure includes post-operative enhancement coverage, meaning that if a small additional correction is needed after surgery, it is already covered. Feinerman Vision offers financing through CareCredit and discusses total cost transparently during the consultation.
Yes. At Feinerman Vision, both eyes are performed on the same day in a single surgical visit, meaning one anesthesia session and one recovery period. This is a meaningful convenience advantage over practices that stage the two eyes weeks apart. The surgeon, facility, and anesthesia fees are billed per eye, so patients treating only one eye are charged accordingly.
Take the Feinerman Vision Candidacy Quiz for a personalized read on whether refractive lens exchange, LASIK, or EVO ICL is the best match for your eyes, your age, and your lifestyle. A few short questions, and you will have a clearer picture before your consultation.
The most important part of the RLE decision is the measurements and the conversation that come before it. Feinerman Vision’s evaluation includes iTrace lens imaging, high-resolution tomography, ocular-surface assessment, retinal evaluation, biometry, a lens-tradeoff discussion, and time with Dr. Feinerman personally to decide whether RLE, EVO ICL, LASIK, or simply watchful management is the right next step.
If the lens is not yet the issue, we will tell you. If it is, we will walk you through every real option, including the tradeoffs.
Feinerman Vision • 320 Superior Avenue, Suite 390, Newport Beach, CA 92663 • (949) 631-4780
This quiz is educational and does not diagnose any condition or guarantee candidacy for any procedure. Candidacy is determined only by a comprehensive evaluation, including corneal imaging and a full eye exam, performed by Gregg Feinerman, MD, FACS. Feinerman Vision · 320 Superior Ave, Suite 390, Newport Beach, CA 92663 · (949) 631-4780 · FeinermanVision.com